LoadingLoadingLoadingNo insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsEach bar is 100% of that source’s money. The notch marks an even split.
Lean is the direction of the latest moves. Descriptive, not advice.
Buys/Adds (3)
Point72
$65.7M
added
Citadel
$59.5M
added
AQR
$34.2M
added
Buys (3)
Lobo Kevin
$642K
bought
Hochman Rodney F
$100K
bought
Yang Watkin Phoebe L.
$63K
bought
Sells (2)
No tracked top-trader positions in GEHC as of Oct 24, 07:37 UTC.
Hyperliquid positioning - not every stock is covered
Last report
Jul 29, 2026
Financial period
Q2 2026
Earnings per share
$1.04 expected
Revenue
Company release
Estimates as of Oct 24, 2026
EPS expected
$1.16 to $1.25
Revenue expected
18 analysts
Last 30 days
Analysts raising estimates
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 29, 2026 | $1.13 / $1.04Yahoo Finance | +9.09% beat | $5.29B No estimate | Unavailable |
| Mar 31, 2026 | Apr 29, 2026 | $0.99 / $1.05Yahoo Finance | -5.71% miss | $5.13B No estimate | Unavailable |
| Dec 31, 2025 | Feb 4, 2026 | $1.44 / $1.40Yahoo Finance | +2.99% beat | $4.67B No estimate | Unavailable |
| Sep 30, 2025 | Oct 29, 2025 | $1.07 / $1.05Yahoo Finance | +2.21% beat | $5.14B No estimate | Unavailable |
| Jun 30, 2025 | Jul 30, 2025 | $1.06 / $0.92Alpha Vantage | +15.22% beat | $5.01B No estimate | Unavailable |
| Mar 31, 2025 | Apr 30, 2025 | $1.01 / $0.91Alpha Vantage | +10.99% beat | $4.78B No estimate | Unavailable |
| Dec 31, 2024 | Feb 13, 2025 | $1.57 / $1.26Alpha Vantage | +24.60% beat | $5.32B No estimate | Unavailable |
| Sep 30, 2024 | Oct 30, 2024 | $1.14 / $1.05Alpha Vantage | +8.57% beat | $4.86B No estimate | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $5.14B | $4.67B | $5.13B | $5.29B |
| Cost of what it sold | $3.15B | $2.13B | $3.15B | $3.12B |
| Gross profit | $1.99B | $2.54B | $1.98B | $2.18B |
| What it spent | ||||
| Research and development | $292.0M | $362.0M | $345.0M | $323.0M |
| Sales and admin | $1.04B | $1.11B | $1.12B | $1.12B |
| Other operating costs | — | $403.0M | — | — |
| Total operating expenses | $1.34B | $1.88B | $1.46B | $1.44B |
| What was left | ||||
| Operating profit | $653.0M | $664.0M | $515.0M | $739.0M |
| Interest on debt | $123.0M | $103.0M | $96.0M | $114.0M |
| Profit before tax | $643.0M | $202.0M | $505.0M | $693.0M |
| Tax | $179.0M | $54.0M | $94.0M | $119.0M |
| Net profit | $446.0M | $184.0M | $389.0M | $573.0M |
| EBITDA | $902.0M | $463.0M | $755.0M | $953.0M |
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bullish
J&J, Smith+Nephew plans for ortho megamerger reportedly fall through
NeutralOct 23FMC launches multiFiltratePRO: Fresenius Medical Care stock gains 1.17 percent
Leans bullishOct 23Is GE HealthCare Technologies (GEHC) Undervalued On Its StarGuide GX Clinical Program?
Leans bullishOct 23Public AI Firm Moves to Secure Nearly 20% of Tampa Health Care Company
Leans bullishOct 22Emmy-Award Winning Television Host Montel Williams to Join Next ‘Let’s Huddle’ Webinar
Leans bullishOct 22Merit Medical Systems, Inc. (MMSI) stock price, news, quote and history
Leans bullishOct 22SBC Medical Initiates Development of a DNA Methylation Test to Estimate Biological Age
Leans bullishOct 22Alpha Tau signs MOU with Samsung Medical Center for pancreatic cancer trial
NeutralOct 22
